Ultragenyx Pharmaceutical Inc. - Net Worth and Insider Trading

Ultragenyx Pharmaceutical Inc. Net Worth

The estimated net worth of Ultragenyx Pharmaceutical Inc. is at least $47 Million dollars as of 2024-03-29. Ultragenyx Pharmaceutical Inc. is the Director of Arcturus Therapeutics Holdings Inc and owns about 1,400,000 shares of Arcturus Therapeutics Holdings Inc (ARCT) stock worth over $47 Million. Details can be seen in Ultragenyx Pharmaceutical Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ultragenyx Pharmaceutical Inc. has not made any transactions after 2021-08-11 and currently still holds the listed stock(s).

Transaction Summary of Ultragenyx Pharmaceutical Inc.

To

Ultragenyx Pharmaceutical Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ultragenyx Pharmaceutical Inc. owns 2 companies in total, including Arcturus Therapeutics Holdings Inc () , and Solid Biosciences Inc () .

Click here to see the complete history of Ultragenyx Pharmaceutical Inc.’s form 4 insider trades.

Insider Ownership Summary of Ultragenyx Pharmaceutical Inc.

Ticker Comapny Transaction Date Type of Owner
Arcturus Therapeutics Holdings Inc 2021-08-11 director & 10 percent owner
Solid Biosciences Inc 2020-10-22 10 percent owner

Ultragenyx Pharmaceutical Inc. Latest Holdings Summary

Ultragenyx Pharmaceutical Inc. currently owns a total of 1 stock. Ultragenyx Pharmaceutical Inc. owns 1,400,000 shares of Arcturus Therapeutics Holdings Inc (ARCT) as of August 11, 2021, with a value of $47 Million.

Latest Holdings of Ultragenyx Pharmaceutical Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARCT Arcturus Therapeutics Holdings Inc 2021-08-11 1,400,000 33.71 47,194,000

Holding Weightings of Ultragenyx Pharmaceutical Inc.


Ultragenyx Pharmaceutical Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Ultragenyx Pharmaceutical Inc. has made a total of 2 transactions in Arcturus Therapeutics Holdings Inc (ARCT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Arcturus Therapeutics Holdings Inc is the sale of 800,000 shares on August 11, 2021, which brought Ultragenyx Pharmaceutical Inc. around $44 Million.

Insider Trading History of Ultragenyx Pharmaceutical Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ultragenyx Pharmaceutical Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ultragenyx Pharmaceutical Inc. Ownership Network

Ownership Network List of Ultragenyx Pharmaceutical Inc.

No Data

Ownership Network Relation of Ultragenyx Pharmaceutical Inc.


Ultragenyx Pharmaceutical Inc. Owned Company Details

What does Arcturus Therapeutics Holdings Inc do?

Who are the key executives at Arcturus Therapeutics Holdings Inc?

Ultragenyx Pharmaceutical Inc. is the director & 10 percent owner of Arcturus Therapeutics Holdings Inc. Other key executives at Arcturus Therapeutics Holdings Inc include Chief Scientific Officer & COO Pad Chivukula , See Remarks Keith C Kummerfeld , and director & 10 percent owner & President and CEO Joseph E Payne .

Arcturus Therapeutics Holdings Inc () Insider Trades Summary

Over the past 18 months, Ultragenyx Pharmaceutical Inc. made no insider transaction in Arcturus Therapeutics Holdings Inc (). Other recent insider transactions involving Arcturus Therapeutics Holdings Inc () include a net sale of 116,000 shares made by Pad Chivukula , a net sale of 13,936 shares made by Keith C Kummerfeld , and a net purchase of 5,000 shares made by Joseph E Payne .

In summary, during the past 3 months, insiders sold 26,000 shares of Arcturus Therapeutics Holdings Inc () in total and bought 0 shares, with a net sale of 26,000 shares. During the past 18 months, 129,936 shares of Arcturus Therapeutics Holdings Inc () were sold and 7,222 shares were bought by its insiders, resulting in a net sale of 122,714 shares.

Arcturus Therapeutics Holdings Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcturus Therapeutics Holdings Inc Insider Transactions

No Available Data

Ultragenyx Pharmaceutical Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Ultragenyx Pharmaceutical Inc.. You might contact Ultragenyx Pharmaceutical Inc. via mailing address: 60 Leveroni Court, Novato Ca 94949.

Discussions on Ultragenyx Pharmaceutical Inc.

No discussions yet.